The following corporate finance-related stories were reported by media: * Rottapharm Madaus aims to float a 40 percent stake in an initial public offering that values the Italian pharmaceutical group at up to 2.2 billion euros ($3 billion), a source close to the matter said.* Merck & Co Inc is considering selling a big portfolio of mature drugs that could fetch more than $15 billion, according to people familiar with the matter, as the U.S. drugmaker continues to streamline businesses to focus on high-growth areas.
Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. Shares of MRK fell by 0.27% or $-0.16/share to $58.56. In the past year, the shares have traded as low as $44.62 and as high as $59.00. On average, 11562200 shares of MRK exchange hands on a given day and today's volume is recorded at 13564049.
Source
